Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors

Bioorganic & Medicinal Chemistry
2012.0

Abstract

Natural products have been the subject of interest for drug discovery and as tools for understanding the underlying cellular pathways in various diseases. We present herein the synthesis and evaluation of new analogs of the marine sponge metabolite, debromohymenialdisine, as checkpoint kinase 2 (Chk2) inhibitors. We illustrate herein that slight modifications to the natural product scaffold can induce strong selectivity for Chk2 over Chk1. These Chk2 inhibitors can serve as drug templates or molecular tools to gain insight in Chk2 mediated radioprotection.

Knowledge Graph

Similar Paper

Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors
Bioorganic & Medicinal Chemistry 2012.0
Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine
Bioorganic & Medicinal Chemistry Letters 2004.0
Design of granulatimide and isogranulatimide analogues as potential Chk1 inhibitors: Study of amino-platforms for their synthesis
Bioorganic & Medicinal Chemistry 2014.0
Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates
European Journal of Medicinal Chemistry 2018.0
Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues
Bioorganic & Medicinal Chemistry Letters 2009.0
Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors
Journal of Medicinal Chemistry 2018.0
Synthesis and biological activities of isogranulatimide analogues
Bioorganic & Medicinal Chemistry 2007.0
Design, Synthesis, and Biological Activity of 5,10-Dihydro-dibenzo[b,e][1,4]diazepin-11-one-Based Potent and Selective Chk-1 Inhibitors
Journal of Medicinal Chemistry 2007.0
Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine analogues as novel CHK1 inhibitors
European Journal of Medicinal Chemistry 2018.0
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
European Journal of Medicinal Chemistry 2018.0